Solid-phase chemiluminescence immunoassay for progesterone in unextracted serum

Area of Science:

• Clinical Chemistry
• Immunoassay Technology
• Endocrinology

Background:

• Radioimmunoassay (RIA) for progesterone requires serum extraction and radioligands.
• Developing non-isotopic immunoassays for steroid hormones is an active research area.
• Direct assays simplify sample processing and reduce hazardous waste.

Purpose of the Study:

• To develop and validate a direct, solid-phase chemiluminescence immunoassay (CLIA) for serum progesterone.
• To evaluate the performance of the CLIA compared to established radioimmunoassay methods.
• To assess the utility of CLIA as a convenient alternative for progesterone measurement.

Main Methods:

• A solid-phase immunoassay using anti-progesterone IgG coupled to immunobeads.
• A chemiluminescent ligand marker: progesterone-11 alpha-hemisuccinyl-aminobutylethyl isoluminol conjugate.
• Danazol was used to displace progesterone from binding proteins in unextracted serum.

Main Results:

• The direct CLIA demonstrated comparable sensitivity, specificity, precision, and accuracy to RIA.
• Progesterone values from CLIA showed high correlation with RIA results (r = 0.987).
• The assay requires only 10 microL of unextracted serum.

Conclusions:

• The developed chemiluminescence immunoassay is analytically valid for direct progesterone measurement in serum.
• This method provides a convenient and effective alternative to radioimmunoassay.
• The assay simplifies progesterone testing by eliminating the need for serum extraction.